Advancing Global Health Through Vigilance
We are a team of dedicated scientists, engineers, and healthcare professionals committed to making medicine safer for everyone.
Our Mission & Values
Our work is guided by a core set of principles that ensure we deliver excellence and integrity in everything we do.
Our Journey
MedVax Vigilance was founded in December 2025 in Dar es Salaam, Tanzania, by a multidisciplinary team of public health experts, regulatory specialists, and technology innovators. The organization was established to address the growing need for strong pharmacovigilance systems across Africa, driven by expanding immunization programs, increased access to medicines, and regional regulatory harmonization.
2025–2026
Foundation & Platform Development
Official launch of core operations and development of AI-powered adverse event reporting and monitoring platforms. Initial pilot deployments planned in selected East African healthcare facilities.
2026–2027
Training & Capacity Building
Rollout of accredited pharmacovigilance training programs, including workshops, e-learning modules, and certification initiatives for healthcare professionals and regulators.
2027–2028
Strategic Partnerships
Formation of collaborations with national regulatory authorities, regional bodies such as the East African Community, international organizations, academic institutions, and public health stakeholders.
2028–2030
Africa-Wide Expansion
Scaling services across the continent, integration of advanced predictive analytics, support for the African Medicines Agency initiatives, and expansion into underserved regions.
Today
Building a Safer Future
MedVax Vigilance is building AI-driven pharmacovigilance solutions, accredited training modules, and partnerships to strengthen medicine and vaccine safety systems across Africa.